The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

David C. Mohr

University of California

San Francisco

VAMC, San Francisco

CA 94121

USA

[email]@*.ucsf.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of California, San Francisco, VAMC, San Francisco, CA 94121, USA. 1999 - 2007
  • University of California, San Francisco, USA. 2001 - 2005
  • Departments of Psychiatry and Neurology, and VA Medical Center, University of California-San Francisco, 4150 Clement Street (116-A), USA. 2004

References

  1. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mohr, D.C., Hart, S.L., Julian, L., Tasch, E.S. Mult. Scler. (2007) [Pubmed]
  2. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Mohr, D.C., Pelletier, D. Brain Behav. Immun. (2006) [Pubmed]
  3. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mohr, D.C., Hart, S.L., Fonareva, I., Tasch, E.S. Mult. Scler. (2006) [Pubmed]
  4. Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mohr, D.C., Cox, D., Merluzzi, N. Mult. Scler. (2005) [Pubmed]
  5. A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis. Mohr, D.C., Burke, H., Beckner, V., Merluzzi, N. Mult. Scler. (2005) [Pubmed]
  6. Telephone-administered psychotherapy for depression. Mohr, D.C., Hart, S.L., Julian, L., Catledge, C., Honos-Webb, L., Vella, L., Tasch, E.T. Arch. Gen. Psychiatry (2005) [Pubmed]
  7. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Mohr, D.C., Hart, S.L., Julian, L., Cox, D., Pelletier, D. BMJ (2004) [Pubmed]
  8. The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Mohr, D.C., Classen, C., Barrera, M. Psychol. Med (2004) [Pubmed]
  9. Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis. Mohr, D.C., Genain, C. J. Psychosom. Res (2004) [Pubmed]
  10. The mediating effects of sleep in the relationship between traumatic stress and health symptoms in urban police officers. Mohr, D., Vedantham, K., Neylan, T., Metzler, T.J., Best, S., Marmar, C.R. Psychosom. Med (2003) [Pubmed]
  11. Effects of treatment for depression on fatigue in multiple sclerosis. Mohr, D.C., Hart, S.L., Goldberg, A. Psychosom. Med (2003) [Pubmed]
  12. Couples therapy at end of life. Mohr, D.C., Moran, P.J., Kohn, C., Hart, S., Armstrong, K., Dias, R., Bergsland, E., Folkman, S. Psychooncology (2003) [Pubmed]
  13. Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis. Mohr, D.C., Epstein, L., Luks, T.L., Goodkin, D., Cox, D., Goldberg, A., Chin, C., Nelson, S. J. Consult. Clin. Psychol (2003) [Pubmed]
  14. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Mohr, D.C., Goodkin, D.E., Nelson, S., Cox, D., Weiner, M. Psychosom. Med (2002) [Pubmed]
  15. Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. Mohr, D.C., Cox, D., Epstein, L., Boudewyn, A. J. Behav. Ther. Exp. Psychiatry (2002) [Pubmed]
  16. Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Mohr, D.C., Boudewyn, A.C., Likosky, W., Levine, E., Goodkin, D.E. Ann. Behav. Med (2001) [Pubmed]
  17. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Mohr, D.C., Goodkin, D.E., Islar, J., Hauser, S.L., Genain, C.P. Arch. Neurol. (2001) [Pubmed]
  18. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Mohr, D.C., Boudewyn, A.C., Goodkin, D.E., Bostrom, A., Epstein, L. J. Consult. Clin. Psychol (2001) [Pubmed]
  19. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Mohr, D.C., Likosky, W., Bertagnolli, A., Goodkin, D.E., Van Der Wende, J., Dwyer, P., Dick, L.P. J. Consult. Clin. Psychol (2000) [Pubmed]
  20. The psychosocial impact of multiple sclerosis: exploring the patient's perspective. Mohr, D.C., Dick, L.P., Russo, D., Pinn, J., Boudewyn, A.C., Likosky, W., Goodkin, D.E. Health. Psychol (1999) [Pubmed]
  21. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Mohr, D.C., Likosky, W., Dwyer, P., Van Der Wende, J., Boudewyn, A.C., Goodkin, D.E. Arch. Neurol. (1999) [Pubmed]
 
WikiGenes - Universities